| Application no. and date | 09175877.1 (espacenet) (Federated) (European Patent Register), 20091113 | | Patent/reg. no. and date | DK/EP 2329848, 20121024 | | Publication date | 20110608 | | Priority no. and date | | | EP pub. no. and date |
EP 2329848 20110608 | | Effective date | | | Applicant/owner | Sanofi-Aventis Deutschland GmbH, Brüningstraße 50
65929 Frankfurt am Main, DE | | Applicant ref. no. | 1512177 | | Inventor | Silvestre, Louise, c/o Sanofi-Aventis
Département Brevets
174, Avenue de France
75013 Paris, FR,
Souhami, Elisabeth, c/o Sanofi-Aventis
Département Brevets
174, Avenue de France
75013 Paris, FR,
Wei, Xiaodan, c/o Sanofi-Aventis
1041 Route 202-206
Mail Code: BWD-303A
Bridgewater, NJ 08807, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/155 (2006.01) , A61K 38/26 (2006.01) , A61K 38/28 (2006.01) , A61K 45/06 (2006.01) | | Title | Lixisenatid som supplerende behandling til insulin glargin og metformin til behandling af type 2-diabetes | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
